223 related articles for article (PubMed ID: 1324804)
21. Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jun; 284(5):1116-25. PubMed ID: 11414699
[TBL] [Abstract][Full Text] [Related]
22. Activation of small GTPase Rho is required for autocrine motility factor signaling.
Tsutsumi S; Gupta SK; Hogan V; Collard JG; Raz A
Cancer Res; 2002 Aug; 62(15):4484-90. PubMed ID: 12154059
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta.
Yanagawa T; Watanabe H; Takeuchi T; Fujimoto S; Kurihara H; Takagishi K
Lab Invest; 2004 Apr; 84(4):513-22. PubMed ID: 14968121
[TBL] [Abstract][Full Text] [Related]
24. Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
Silletti S; Paku S; Raz A
Am J Pathol; 1996 May; 148(5):1649-60. PubMed ID: 8623932
[TBL] [Abstract][Full Text] [Related]
25. Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.
Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K
Oncol Rep; 2002; 9(1):125-8. PubMed ID: 11748469
[TBL] [Abstract][Full Text] [Related]
26. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells.
Watanabe H; Nabi IR; Raz A
Cancer Res; 1991 May; 51(10):2699-705. PubMed ID: 2021948
[TBL] [Abstract][Full Text] [Related]
27. Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis.
Silletti S; Raz A
Curr Top Microbiol Immunol; 1996; 213 ( Pt 2)():137-69. PubMed ID: 9053289
[No Abstract] [Full Text] [Related]
28. Autocrine motility factor/phosphoglucose isomerase regulates ER stress and cell death through control of ER calcium release.
Fu M; Li L; Albrecht T; Johnson JD; Kojic LD; Nabi IR
Cell Death Differ; 2011 Jun; 18(6):1057-70. PubMed ID: 21252914
[TBL] [Abstract][Full Text] [Related]
29. Clathrin-mediated endocytosis and recycling of autocrine motility factor receptor to fibronectin fibrils is a limiting factor for NIH-3T3 cell motility.
Le PU; Benlimame N; Lagana A; Raz A; Nabi IR
J Cell Sci; 2000 Sep; 113 ( Pt 18)():3227-40. PubMed ID: 10954421
[TBL] [Abstract][Full Text] [Related]
30. The autocrine motility factor (AMF) and AMF-receptor combination needs sugar chain recognition ability and interaction using the C-terminal region of AMF.
Haga A; Tanaka N; Funasaka T; Hashimoto K; Nakamura KT; Watanabe H; Raz A; Nagase H
J Mol Biol; 2006 May; 358(3):741-53. PubMed ID: 16563432
[TBL] [Abstract][Full Text] [Related]
31. Polyubiquitylation of AMF requires cooperation between the gp78 and TRIM25 ubiquitin ligases.
Wang Y; Ha SW; Zhang T; Kho DH; Raz A; Xie Y
Oncotarget; 2014 Apr; 5(8):2044-51. PubMed ID: 24810856
[TBL] [Abstract][Full Text] [Related]
32. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
[TBL] [Abstract][Full Text] [Related]
33. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
Tanizaki Y; Sato Y; Oka H; Utsuki S; Kondo K; Miyajima Y; Nagashio R; Fujii K
Pathol Int; 2006 Sep; 56(9):510-5. PubMed ID: 16930331
[TBL] [Abstract][Full Text] [Related]
34. Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events.
Timár J; Tóth S; Tóvári J; Paku S; Raz A
Clin Exp Metastasis; 1999; 17(10):809-16. PubMed ID: 11089878
[TBL] [Abstract][Full Text] [Related]
35. Expression of autocrine motility-like factor in rheumatoid synovial fluid.
Watanabe H; Takeuchi K; Chigira M
J Rheumatol; 1994 Jan; 21(1):37-40. PubMed ID: 8151584
[TBL] [Abstract][Full Text] [Related]
36. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence.
Nakamori S; Watanabe H; Kameyama M; Imaoka S; Furukawa H; Ishikawa O; Sasaki Y; Kabuto T; Raz A
Cancer; 1994 Oct; 74(7):1855-62. PubMed ID: 8082090
[TBL] [Abstract][Full Text] [Related]
37. Multiple use of a signal transduction pathway in tumor cell invasion.
Tímár J; Rásó E; Fazakas ZS; Silletti S; Raz A; Honn KV
Anticancer Res; 1996; 16(6A):3299-306. PubMed ID: 9042304
[TBL] [Abstract][Full Text] [Related]
38. The role of autocrine motility factor in tumor and tumor microenvironment.
Funasaka T; Raz A
Cancer Metastasis Rev; 2007 Dec; 26(3-4):725-35. PubMed ID: 17828376
[TBL] [Abstract][Full Text] [Related]
39. Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
Jiang WG; Raz A; Douglas-Jones A; Mansel RE
J Histochem Cytochem; 2006 Feb; 54(2):231-41. PubMed ID: 16204225
[TBL] [Abstract][Full Text] [Related]
40. Expression of Gp78/Autocrine Motility Factor Receptor and Endocytosis of Autocrine Motility Factor in Human Thyroid Cancer Cells.
Wiseman SM; Kojic LD; Kassian K; Jones SJ; Joshi B; Nabi IR
Cureus; 2019 Jun; 11(6):e4928. PubMed ID: 31431834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
